Velodyne Lidar Experts to Address Perception Breakthroughs for Autonomous Vehicles at IDTechEx
The world’s largest event on emerging technologies, IDTechEx Show!, will feature presentations from two senior Velodyne Lidar, Inc. experts who will address the future of lidar technology. The discussions will focus on how lidar will enable advanced vehicle safety and performance for autonomous vehicles. More than 3,500 people from a wide range of disciplines, from end-user executives to manufacturers and system integrators, are expected to attend the event at the Santa Clara (Calif.) Convention Center on Nov. 14-15.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181108005503/en/
Anand Gopalan, Ph.D., Chief Technology Officer (CTO) at Velodyne Lidar, is presenting on lidar technology at the IDTechEx Show!. (Photo: Business Wire)
Velodyne Lidar’s Anand Gopalan, Ph.D., Chief Technology Officer (CTO) and Stephen Nestinger, Ph.D., Director of Mechanical Engineering, will lead conference sessions about the levels of lidar sensor performance and reliability required for autonomous vehicles to operate safely. Gopalan and Nestinger will review how Velodyne’s proven product line of lidar sensors enable autonomy and improve safety in lower-speed urban environments and at highway speeds. Additional discussion points will focus on Velodyne‘s continued status as the industry leader in the design and manufacture of lidar sensors, the essential components of self-driving cars. The sessions will also outline the company’s commitment to inventing and refining new technologies.
How Lidar is Shaping Our Autonomous Future
IDTechEx Show! attendees will hear Gopalan discuss lidar’s role and importance in autonomous perception. The session will also address various misconceptions about the current state of lidar technology and its future outlook.
“As the leader in lidar technology, Velodyne has a unique, bird's-eye view on where the autonomous mobility industry is headed in terms of the hardware requirements for perception. This session will explore why lidar is needed for level 4 and level 5 autonomous vehicles, and how lidar can vastly enhance the performance of level 2+ advanced driver-assistance systems (ADAS). It will also examine what lidar will and won’t be able to do in the future as the technology matures,” said Gopalan.
Gopalan’s session, titled “The Essential Role of Lidar Technology in Shaping Our Autonomous Future,” takes place on Nov. 15, from 8:40 a.m. to 9:00 a.m. in Grand Ballroom C.
At Velodyne Lidar, Gopalan is responsible for the advanced product and technology developments that are powering the company’s latest lidar products. He is a seasoned technology executive with experience building and leading worldwide engineering organizations for the development of products in consumer, networking, and enterprise domains.
Providing Precise Situational Awareness in a Range of Applications
Nestinger will discuss how Velodyne’s revolutionary sensing portfolio provides precise situational awareness for applications ranging from forest canopy surveying to autonomous vehicles and embeddable ADAS. The session will also address technological development towards the integration of additional sensing modalities that will enhance perception and save lives.
Nestinger’s session, titled “Illuminating the Perception Horizon with Multi-Modality 3D Lidar,” takes place on Nov. 14, from 5:40 p.m. to 6:00 p.m. in Grand Ballroom F.
Nestinger joined Velodyne Lidar in 2014 and has contributed to the design, development, and production of Velodyne’s world renowned lidar sensors. Before joining Velodyne Lidar, he was an Assistant Professor in the mechanical engineering department and robotics engineering program at the Worcester Polytechnic Institute.
About Velodyne Lidar
Founded in 1983 and headquartered in Silicon Valley, Velodyne is a technology company known worldwide for its real-time 3D lidar computing and software platforms. The company evolved after founder David Hall invented the HDL-64 Solid-State Hybrid lidar sensor in 2005. Since then, Velodyne Lidar, Inc. emerged as the unmatched market leader of real-time 3D vision systems used in a variety of commercial applications including autonomous vehicles, vehicle safety systems, mobile mapping, aerial mapping, and security. Its products range from the high-performance, surround view Ultra-Puck™ VLP-32, classic HDL-32/64 and cost-effective VLP-16, the new VLS-128, to the upcoming, hidden Velarray™. Velodyne’s rich suite of perception software and algorithms are the key enablers of its perception systems. Velodyne supports customers from offices in San Jose, Detroit, Frankfurt, and Beijing. For more information, visit http://www.velodynelidar.com.
Landis Communications for Velodyne Lidar, Inc.
David Cumpston, 415-359-2316
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Tilaa tiedotteet sähköpostiisi
Haluatko tietää asioista ensimmäisten joukossa? Kun tilaat mediatiedotteemme, saat ne sähköpostiisi välittömästi julkaisuhetkellä. Tilauksen voit halutessasi perua milloin tahansa.
Lue lisää julkaisijalta Business Wire
Vargatef® plus docetaxel could be an option after failure of immunotherapy in lung cancer14.12.2018 12:07 | Tiedote
Boehringer Ingelheim announced today the first interim results of VARGADO, an ongoing non-interventional study in routine clinical practice in Germany evaluating the efficacy and safety of Vargatef® (nintedanib) and docetaxel in patients with stage III/IV locally advanced or metastatic non-small cell lung cancer (NSCLC) of adenocarcinoma histology. The study consists of three cohorts, two of which allow for prior treatment with immune checkpoint inhibitors (ICIs) either in combination with chemotherapy in the first-line or as monotherapy in the second-line of treatment. The interim results from Cohort B (first-line chemotherapy, second-line immune checkpoint inhibitors, third-line Vargatef® plus docetaxel) were presented today at ESMO Immuno-Oncology Congress 2018 in Geneva.1 Despite a limited sample size, the VARGADO study adds to the body of evidence for nintedanib in lung adenocarcinoma following pre-treatment with chemotherapy and ICIs.1,3 The addition of nintedanib to docetaxel ha
Alps Electric to Exhibit at CES 2019 as Alps Alpine for the First Time14.12.2018 10:58 | Tiedote
Japanese comprehensive electronic components manufacturer Alps Electric Co., Ltd. (TOKYO:6770) (Ota-ku, Tokyo; President: Toshihiro Kuriyama) will exhibit at CES 2019, to open at the Las Vegas Convention and World Trade Center in Las Vegas, Nevada, in the United States on January 8. Alps Electric will be taking part as a new company, Alps Alpine Co., Ltd., for the first time. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181213006022/en/ Alps Alpine's new touch input device for automotive (Graphic: Business Wire) At CES 2019, an exposition of cutting-edge technologies brought together from around the world, Alps Electric will present a variety of technologies in response to the major trends in automotive development referred to as “CASE”—namely connected cars, autonomous driving, sharing and services, and electric vehicles. Making its first appearance at the show as a new company following its business integration with subs
Kalray Joins Autoware Foundation as Founding Premium Member14.12.2018 10:18 | Tiedote
Kalray (Euronext Growth Paris – ALKAL), a pioneer in processors for new intelligent systems, today announced it has joined the Autoware Foundation as a founding premium member. The formation of Autoware was formally announced on December 10, 2018 with a mission of facilitating the deployment of Autoware open-source projects enabling self-driving mobility. The Autoware Foundation creates synergies between corporate development and academic research, enabling autonomous driving technology for everyone. "We are glad to have the presence of Kalray as a premium member of the Autoware Foundation. Having highly efficient hardware solutions supporting autonomous driving software is instrumental to boost the deployment of Autoware in the market!" said Shinpei Kato, member of the Board of Directors for Autoware. Autonomous driving demands massive processing power, low power consumption and bulletproof safety and security to handle critical functions like AI processing, acceleration of perception
IDEMIA Provides Subscription Management Platform to dtac in Thailand to Offer eSIM Connected Watches to All Its Subscribers.14.12.2018 06:30 | Tiedote
IDEMIA, the global leader in Augmented Identity, has been selected by dtac, the leading mobile operator in Thailand, to offer connectivity on eSIM connected watches. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181213005934/en/ Credits : IDEMIA IDEMIA’s Subscription Management platform (or remote SIM provisioning) is the technology that remotely connects the embedded SIM of a smartwatch to dtac’s network without inserting a physical SIM card. Indeed, the IDEMIA Subscription Manager is a server which securely manages the lifecycle of mobile subscriptions and profiles for eSIM-ready consumer devices and wearables. This solution is compliant with the latest GSMA (Global System for Mobile Communications Association) standards to ensure global interoperability and, thanks to the scalability of the platform, the operator will be able to serve up to millions of customers during peak times. dtac subscribers now have the possibilit
CHMP Grants Positive Opinion for New Indication of Clovis Oncology’s Rubraca®▼ (rucaparib) Tablets as Maintenance Treatment for Women with Relapsed Ovarian Cancer13.12.2018 20:46 | Tiedote
Clovis Oncology, Inc. (NASDAQ: CLVS) today announced that the European Union’s (EU) European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending an additional indication to include rucaparib as monotherapy for the maintenance treatment of adult patients with platinum-sensitive relapsed high-grade epithelial ovarian, fallopian tube, or primary peritoneal cancer who are in response (complete or partial) to platinum-based chemotherapy. EC approval is anticipated in the first quarter of 2019. Once approved, Rubraca’s indication will expand beyond its initial Marketing Authorization in Europe granted in May 2018 for adult patients with platinum-sensitive, relapsed or progressive, BRCA mutated (germline and/or somatic), high-grade epithelial ovarian, fallopian tube, or primary peritoneal cancer, who have been treated with two or more prior lines of platinum-based chemotherapy, and who are unable to tolerate further platinum
Dole Food Company Sells Fresh Cut Business in Sweden and Finland13.12.2018 20:00 | Tiedote
Dole Food Company, Inc., announced today an agreement to sell Saba Fresh Cuts AB and Saba Fresh Cuts OY to BAMA International. Saba Fresh Cuts AB—with production facility in Helsingborg Sweden—and Saba Fresh Cuts OY—with production facility in Espoo Finland—are producers of washed and ready-to-eat salads. The companies prepare and sell various fresh-cut salads and vegetables to the retail and foodservice industry in Sweden, Denmark, Finland, Germany and the Baltic States. The sale of Saba Fresh Cuts AB was a necessary condition of the European Commission’s approval of the investment by Total Produce into Dole in July 2018. “I am very pleased with the outcome of this sale in meeting the EU’s requirement,” said Mr. Johan Linden, President and Chief Executive Officer of Dole Food Company, “and I am confident that Saba Fresh Cuts will be in good hands under BAMA’s ownership.” "We are pleased to announce this agreement with Dole for Saba Fresh Cuts. Convenience products and ready-to-eat sal
Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.Tutustu uutishuoneeseemme